79 related articles for article (PubMed ID: 8605571)
1. Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.
Forsythe SD; Pu T; Andrews SG; Madigan JP; Sadowski SM
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568572
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Models of Neuroendocrine Neoplasia.
Sedlack AJH; Saleh-Anaraki K; Kumar S; Ear PH; Lines KE; Roper N; Pacak K; Bergsland E; Quelle DE; Howe JR; Pommier Y; Del Rivero J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428741
[TBL] [Abstract][Full Text] [Related]
3. The endocrine pancreas and its tumors.
Asa SL
Endocr Pathol; 1993 Sep; 4(3):120-130. PubMed ID: 32138429
[TBL] [Abstract][Full Text] [Related]
4. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
Kawasaki K; Fujii M; Sato T
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice.
Yu R; Dhall D; Nissen NN; Zhou C; Ren SG
PLoS One; 2011; 6(8):e23397. PubMed ID: 21853126
[TBL] [Abstract][Full Text] [Related]
6. Transgenic models of pancreatic cancer.
Lowy AM
Int J Gastrointest Cancer; 2003; 33(1):71-8. PubMed ID: 12909739
[No Abstract] [Full Text] [Related]
7. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models.
Bouvet M; Yang M; Nardin S; Wang X; Jiang P; Baranov E; Moossa AR; Hoffman RM
Clin Exp Metastasis; 2000; 18(3):213-8. PubMed ID: 11315094
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice.
Drucker DJ
Am J Physiol; 1994 Nov; 267(5 Pt 1):E629-35. PubMed ID: 7977712
[TBL] [Abstract][Full Text] [Related]
10. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
Asa SL; Lee YC; Drucker DJ
Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
[TBL] [Abstract][Full Text] [Related]
11. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor.
Drucker DJ; Lee YC; Asa SL; Brubaker PL
Mol Endocrinol; 1992 Dec; 6(12):2175-84. PubMed ID: 1491697
[TBL] [Abstract][Full Text] [Related]
13. Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice.
Lee YC; Asa SL; Drucker DJ
J Biol Chem; 1992 May; 267(15):10705-8. PubMed ID: 1587847
[TBL] [Abstract][Full Text] [Related]
14. Region- and age-specific differences in proglucagon gene expression in the central nervous system of wild-type and glucagon-simian virus-40 T-antigen transgenic mice.
Lee YC; Campos RV; Drucker DJ
Endocrinology; 1993 Jul; 133(1):171-7. PubMed ID: 8319563
[TBL] [Abstract][Full Text] [Related]
15. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
